NCT06789042View on ClinicalTrials.gov

Dexamethasone for ESPB in Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

July 18, 2025

Conditions
Hip OsteoarthritisHip ArthropathyHip Arthritis
Interventions
DRUG

0.9%NaCl

20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl

DRUG

Dexamethasone 4mg

20ml 0.2% Ropivacaine + 4mg Dexamethasone

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06789042 - Dexamethasone for ESPB in Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter